Ischemia Technologies Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $22.4M

Ischemia Technologies General Information

Description

Developer of vitro diagnostic products. The company develops, manufactures and markets diagnostic devices for vitro diagnostic tests specifically aimed at cardiac ischemia involving insufficient blood supply to the heart due to partial or complete obstruction of a coronary artery, thereby enabling medical professionals to address acute clinical conditions that require an immediate diagnosis.

Contact Information

Website
www.ischemia.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Arvada, CO 80003
  • United States
+1 (720)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Alere
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Arvada, CO 80003
  • United States
+1 (720)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ischemia Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 14-Feb-2005 $22.4M Completed Generating Revenue
6. Later Stage VC 09-Nov-2004 Completed Generating Revenue
5. Later Stage VC (Series D) 29-Aug-2003 Completed Generating Revenue
4. Later Stage VC (Series C) 10-Jul-2001 Completed Generating Revenue
3. Early Stage VC (Series B) 21-Dec-2000 Completed Generating Revenue
2. Early Stage VC (Series A) 19-Mar-1999 $4.47M $6.47M Completed Startup
1. Seed Round $2M $2M Completed Startup
To view Ischemia Technologies’s complete valuation and funding history, request access »

Ischemia Technologies Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 5,500,000 $0.001000 8% $2 $2 $2 27.04%
Series A 2,233,809 $0.001000 8% $2 $2 $2 10.98%
To view Ischemia Technologies’s complete cap table history, request access »

Ischemia Technologies Patents

  • 81

    Total Documents Applications and Grants

  • Total Patents Families

  • 22

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Ischemia Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080305550-A1 Targets for detection of ischemia Inactive 21-Jan-2005
EP-1856645-A2 Targets for detection of ischemia Inactive 21-Jan-2005
EP-1856645-A4 Targets for detection of ischemia Inactive 21-Jan-2005
US-20050004485-A1 Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin Active 19-May-2003
AU-2004240557-A1 Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin Inactive 19-May-2003 A61B5/14546
To view Ischemia Technologies’s complete patent history, request access »

Ischemia Technologies Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Venture Alliance Accelerator/Incubator Minority
KB Partners Venture Capital Minority
Piedmont Venture Partners Venture Capital Minority
Plymouth Growth Venture Capital Minority
Quest Capital Partnership Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Ischemia Technologies FAQs

  • When was Ischemia Technologies founded?

    Ischemia Technologies was founded in 1997.

  • Where is Ischemia Technologies headquartered?

    Ischemia Technologies is headquartered in Arvada, CO.

  • What industry is Ischemia Technologies in?

    Ischemia Technologies’s primary industry is Diagnostic Equipment.

  • Is Ischemia Technologies a private or public company?

    Ischemia Technologies is a Private company.

  • What is the current valuation of Ischemia Technologies?

    The current valuation of Ischemia Technologies is .

  • What is Ischemia Technologies’s current revenue?

    The current revenue for Ischemia Technologies is .

  • How much funding has Ischemia Technologies raised over time?

    Ischemia Technologies has raised $31.5M.

  • Who are Ischemia Technologies’s investors?

    Global Venture Alliance, KB Partners, Piedmont Venture Partners, Plymouth Growth, and Quest Capital Partnership are 5 of 9 investors who have invested in Ischemia Technologies.

  • When was Ischemia Technologies acquired?

    Ischemia Technologies was acquired on 14-Feb-2005.

  • Who acquired Ischemia Technologies?

    Ischemia Technologies was acquired by Alere.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »